LianBio Intellectual Property Contracts & Agreements

19 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to the License, Development and Commercialization Agreement, dated as of March 16, 2023, by and between Nanobiotix S.A. and Lian Oncology Limited
License Agreements
LianBio
Biotechnology
2023
Contribution, Assignment and Assumption Agreement, dated as of September 28, 2021, by and among Lian Oncology, Lian Oncology Limited and LianBio relating to the Exclusive License...
License Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement, dated as of September 28, 2021, by and among LianBio Licensing, LLC, Lian Oncology and LianBio relating to the Exclusive License...
License Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement, dated as of September 28, 2021, by and among Lian Oncology, Lian Oncology Limited and LianBio relating to the Exclusive License...
License Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement, dated as of September 28, 2021, by and among LianBio Licensing, LLC, Lian Oncology and LianBio relating to the Exclusive License...
License Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement, dated as of September 28, 2021, by and among Lian Cardviovascular, Lian Cardiovascular Limited and LianBio relating to the...
License Agreements
LianBio
Biotechnology
NY
2021
Contribution, Assignment and Assumption Agreement, dated as of September 28, 2021, by and among LianBio Licensing, LLC, Lian Cardviovascular, and LianBio relating to the Exclusive...
License Agreements
LianBio
Biotechnology
NY
2021
Co-Development and License Agreement, dated March 1, 2021, by and between LianBio Respiratory Limited and ReViral Ltd
License Agreements
LianBio
Biotechnology
DE
2021
License, Development and Commercialization Agreement, dated May 11, 2021, by and between Nanobiotix S.A. and LianBio Oncology Limited
License Agreements
LianBio
Biotechnology
2021
Development and License Agreement, dated March 26, 2021, by and between LianBio Ophthalmology Limited and Tarsus Pharmaceuticals, Inc
License Agreements
LianBio
Biotechnology
NY
2021
Third Amendment to the Exclusive License Agreement, dated December 17, 2020, by and among LianBio, LianBio Licensing LLC and Navire Pharma, Inc
License Agreements
LianBio
Biotechnology
2021
Second Amendment to the Exclusive License Agreement, dated September 28, 2020, by and among LianBio, LianBio Licensing LLC and Navire Pharma, Inc
License Agreements
LianBio
Biotechnology
2021
First Amendment to the Exclusive License Agreement, dated September 23, 2020, by and among LianBio, LianBio Licensing LLC and Navire Pharma, Inc
License Agreements
LianBio
Biotechnology
2021
Exclusive License Agreement, dated August 9, 2020, by and among LianBio, LianBio Licensing LLC and Navire Pharma, Inc
License Agreements
LianBio
Biotechnology
NY
2021
Amendment to the Exclusive License Agreement, dated September 26, 2020, by and between LianBio and QED Therapeutics, Inc
License Agreements
LianBio
Biotechnology
2021
Exclusive License Agreement, dated October 16, 2019, by and between LianBio and QED Therapeutics, Inc
License Agreements
LianBio
Biotechnology
NY
2021
Second Amendment to the Exclusive License Agreement, dated January 4, 2021, by and among LianBio, LianBio Licensing LLC and MyoKardia, Inc
License Agreements
LianBio
Biotechnology
2021
Amendment to the Exclusive License Agreement, dated October 8, 2020, by and among LianBio, LianBio Licensing LLC and MyoKardia, Inc
License Agreements
LianBio
Biotechnology
2021
Exclusive License Agreement, dated August 10, 2020, by and among LianBio, LianBio Licensing LLC and MyoKardia, Inc
License Agreements
LianBio
Biotechnology
NY
2021